Development

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

SEDDS and SMEDDS improve solubility and permeability while expanding efficacy and applicability.

Lipids for Self-Emulsifying Drug Delivery Systems

The organizers of Pharmapack Europe have released the results of its global drug delivery and packaging survey, demonstrating the continuation of the United States’ lead in innovation.

US Leads the Way for Drug Device Innovation but Lags Behind for Sustainability, Notes Pharmapack 2021 Report

BioMed X has partnered with Janssen to start two new research programs for autoimmune diseases and drug delivery.

BioMed X and Janssen Start Up Research Programs in Autoimmunity and Drug Delivery

Glenmark Pharmaceuticals has partnered with SaNOtize to manufacture, market, and distribute NONS to India, Singapore, Malaysia, Hong Kong, and more.

Nitric Oxide Nasal Spray for COVID-19 to Be Distributed to India and Other Asia Markets

BioMed X Institute and Janssen Research & Development to start two new research programs in the field of autoimmune diseases and drug delivery.

Janssen Collaborates with BioMedX in Autoimmunity and Drug Delivery Research

Deanna Mudie, PhD, is principal scientist, Lonza, Bend, OR, USA.

Amorphous solid dispersions can overcome the pH effect encountered with oral oncology medications.

In-Vivo Demonstration of Enhanced Bioavailability of Acalabrutinib ASD Tablets

UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.

SPI Pharma Introduces Platform for Orally Disintegrating Tablets

Pharmapack Europe event organizers have revealed increased levels of innovation in drug delivery across the industry, substantiated by the level of regulatory approvals.

Pharmapack Innovation Index Reveals Continuing Innovation in Drug Delivery Across Europe

Evonik and Stanford University have signed a research collaboration to develop and market a new drug delivery platform for mRNA and gene therapy.

Evonik and Stanford University Partner to Develop mRNA Drug Delivery Technology

Aptamer Group and PinotBio have formed a strategic collaboration aimed at the development of new drug conjugates for targeted drug delivery.